Title : ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis.

Pub. Date : 2021 Oct

PMID : 34804841






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Background: In bone metastatic castration-resistant prostate cancer (bmCRPC) treated with Enzalutamide commonly used prostate-specific antigen (PSA) can be misleading since initial PSA-flares may occur. enzalutamide kallikrein related peptidase 3 Homo sapiens